Search results
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
KAMR Amarillo· 4 hours ago...Approximately $70 million equity investment in NovavaxUp to $700 million in COVID-19 and combination product near-term milestones, plus ongoing tiered royalties on product salesUp to $200 million in milestones plus royalties for each new vaccine developed utilizing Novavax's Matrix-MTM...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 hours agoNovavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines PR Newswire GAITHERSBURG ...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 1 day agoIt provides an alternate treatment pathway for people who might be apprehensive of mRNA technology....
